From Morningstar:

Michael Field and James Gard discuss the mixed picture of earnings season. Some companies have struggled while others have seen growth. Consumer-facing firms have faced difficulties as consumers reach their limit on price increases. Luxury goods have also seen a mixed performance, with some companies thriving and others struggling. Additionally, companies with exposure to AI have seen high valuations, making it difficult for investors to find attractive entry points. Pharmaceutical companies are also facing challenges with GLP-1. It’s a tricky time for investors as they navigate through the various sectors and market conditions.



Read more: Earnings Season: The Good, The Bad & The Ugly